S&P 500
(-0.14%) 5 461.85 points
Dow Jones
(-0.10%) 39 072 points
Nasdaq
(0.12%) 17 739 points
Oil
(-0.62%) $80.33
Gas
(-4.32%) $2.64
Gold
(-0.76%) $2 313.00
Silver
(0.15%) $28.91
Platinum
(2.36%) $1 009.70
USD/EUR
(0.29%) $0.936
USD/NOK
(0.74%) $10.68
USD/GBP
(0.48%) $0.792
USD/RUB
(-0.13%) $87.38

Realtime updates for Xenon Pharmaceuticals Inc [XENE]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology
Last Updated26 Jun 2024 @ 11:41

-3.14% $ 35.84

Live Chart Being Loaded With Signals

Commentary (26 Jun 2024 @ 11:41):
Our systems believe the stock currently is undervalued by 0.27% compare to its pairs and should correct upwards.
Profile picture for Xenon Pharmaceuticals Inc

Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada...

Stats
Today's Volume 160 022
Average Volume 364 582
Market Cap 2.70B
EPS $-0.620 ( Q1 | 2024-05-09 )
Next earnings date ( $0 ) 2024-08-07
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -13.18
(Sector) 42.63
(Industry) 24.32
ATR14 $0.0790 (0.22%)
AADI -3.53%
ABCL 1.47%
ABCM 0.04%
ABEO -2.37%
ABIO -2.23%
ABOS 0.00%
ABSI 1.70%
ABUS -2.30%
ABVX -2.03%
ACAD -0.64%
ACER -17.95%
ACET -5.41%
ACGN 1.29%
ACHL -2.22%
ACHV -1.29%
ACIU -1.75%
ACLX 0.25%
ACRV -5.61%
ACST -3.58%
ACXP 1.38%
ADAG 4.64%
ADAP -3.79%
ADGI 0.87%
ADIL 0.54%
ADMA -2.82%
ADPT -0.14%
ADTX -3.47%
ADVM -3.47%
ADXN -1.60%
AEON -3.74%
AEZS -2.51%
AFMD -0.61%
AGEN -2.82%
AGIO -2.49%
AGLE 6.66%
AGTC 0.00%
AIKI 0.85%
AIMDW -13.88%
AKBA -2.28%
AKRO -3.15%
AKTX 4.08%
AKUS 0.00%
ALBO 0.00%
ALDX -2.52%
ALEC -1.83%
ALGS -2.06%
ALKS -0.23%
ALLK -8.90%
ALLO -4.64%
ALLR -3.41%
ALNA 3.16%
ALNY 2.36%
ALPN 0.02%
ALPX 0.00%
ALRN 0.33%
ALT -9.49%
ALVR -0.40%
ALXN 0.00%
ALXO -10.89%
ALZN 2.04%
AMRN 0.56%
AMTI -3.13%
ANAB 1.05%
ANEB -1.52%
ANGN 0.00%
ANIX -1.62%
ANL -6.60%
ANNX -1.53%
ANPC -3.15%
APGE -1.25%
APGN 8.48%
APGNW 30.65%
APLM -5.01%
APLS 0.12%
APLT -3.94%
APM -2.94%
APOP 0.38%
APRE 0.61%
APTO 6.30%
APTX 3.17%
APVO 0.18%
ARAV -13.39%
ARCT -4.61%
ARDS -14.23%
ARDX -0.66%
ARGX -0.74%
ARNA 0.00%
ARPO -0.90%
ARQT -1.41%
ARTL -2.50%
ARTLW 0.00%
ARVN 6.30%
ARWR -1.75%
ASLN -5.07%
ASMB -5.83%
ASND -1.45%
ATAI -1.48%
ATHA 5.48%
ATHE 1.12%
ATHX -33.50%
ATNF 0.99%
ATOS 1.46%
ATRA -2.83%
ATXI 1.93%
ATXS -0.83%
AUPH -0.99%
AURA 1.18%
AUTL -1.87%
AVBP -4.23%
AVEO 0.00%
AVIR -0.44%
AVRO -1.41%
AVTE -4.83%
AVTX -1.25%
AVXL -3.21%
AXLA 0.00%
AXSM -1.91%
AYLA 0.00%
AZRX 2.07%
BBI 2.17%
BBIO 0.77%
BCAB 2.94%
BCDA -2.05%
BCDAW -41.77%
BCEL 0.00%
BCLI 5.82%
BCRX 0.99%
BCTX 8.16%
BCTXW -17.41%
BCYC 1.26%
BDRX -4.94%
BDTX -1.07%
BEAM 0.58%
BFRA -2.91%
BGNE -3.00%
BIOR -3.80%
BIVI 5.77%
BLCM -6.68%
BLI -5.88%
BLPH 0.00%
BLRX -0.89%
BLTE -0.62%
BLU 0.03%
BLUE -0.34%
BMEA -11.13%
BMRN 0.47%
BNOX -2.22%
BNTC -2.39%
BNTX -1.78%
BOLD -8.58%
BOLT 0.72%
BPMC -1.25%
BPTH 1.42%
BPTS -13.47%
BRNS -0.74%
BRTX -2.36%
BTAI 24.78%
BTTX 53.33%
BTX 0.05%
BVXV 0.74%
BXRX 7.39%
BYSI 3.39%
CABA 0.48%
CADL -2.12%
CALA 0.00%
CALC -1.77%
CALT -1.14%
CAPR -2.80%
CARA 0.24%
CARM 11.34%
CASI -1.65%
CATB -6.97%
CBAY 0.03%
CBIO -2.65%
CBLI -7.31%
CBUS -6.50%
CCCC -5.41%
CCXI 0.00%
CDAK 0.00%
CDIO -2.20%
CDIOW 24.00%
CDMO -2.68%
CDMOP 0.04%
CDT -12.20%
CDTTW -39.60%
CDTX -1.92%
CDXC 0.41%
CDXS 6.21%
CELC -4.58%
CELU -1.97%
CELUW 11.80%
CERC -1.68%
CERE -1.09%
CERO -3.47%
CEROW -10.18%
CFRX -27.95%
CGEM -2.20%
CGEN -3.87%
CGON -1.56%
CGTX -4.47%
CHMA -6.00%
CHRS 0.32%
CINC 0.00%
CING 2.26%
CINGW 34.95%
CKPT -3.35%
CLBS -16.75%
CLDX -2.29%
CLGN 0.34%
CLLS -4.15%
CLNN 2.42%
CLNNW 0.00%
CLRB 6.99%
CLSD 0.00%
CLSN -0.68%
CLVS 0.00%
CMMB -0.97%
CMND 0.78%
CMPI 0.00%
CMPX -8.25%
CMRA 0.00%
CMRAW 33.33%
CMRX -3.04%
CNCE 0.00%
CNSP -38.02%
CNST 0.00%
CNTA -0.51%
CNTB -2.25%
CNTX -6.85%
COCP -2.00%
COEPW 32.45%
COGT -3.00%
CORT 1.97%
COYA -1.46%
CPRX -1.22%
CRBP -3.36%
CRBU -4.83%
CRDF -1.77%
CRGX 0.47%
CRIS -0.38%
CRNX -6.15%
CRSP 1.11%
CRTX 2.63%
CRVO -2.50%
CRVS 1.82%
CSBR -1.59%
CTCX -1.60%
CTIC 0.06%
CTMX -2.89%
CTNM -0.55%
CTXR 1.36%
CUE 4.50%
CVAC -2.69%
CVKD -5.23%
CWBR 2.80%
CYAD -12.96%
CYCC 8.18%
CYCCP 5.49%
CYCN 0.43%
CYT -2.27%
CYTK -1.78%
CYTO -1.82%
DARE 6.33%
DAWN 0.37%
DBTX -0.81%
DBVT 4.17%
DFFN 10.28%
DICE 0.06%
DMAC 29.65%
DNLI -1.70%
DNTH -8.18%
DOMH -1.58%
DRMA -1.10%
DRMAW -1.25%
DRNA 0.00%
DRTS 1.85%
DRTSW 0.00%
DRUG 0.95%
DSGN -1.21%
DTIL 0.56%
DYAI 10.32%
EARS -1.77%
EDIT -3.12%
EDSA 3.19%
EFTR 1.79%
EFTRW -51.85%
EIGR -9.21%
ELAB -1.00%
ELDN 7.56%
ELEV -5.81%
ELOX 7.69%
ELTX -0.88%
ELVN -4.43%
ELYM 1.26%
ENGN -4.44%
ENGNW 0.12%
ENLV 2.54%
ENOB 1.79%
ENSC 4.17%
ENTA -0.57%
ENTO -2.47%
ENTX 2.08%
ENVB 1.10%
EPIX -0.31%
EPRX -2.97%
EPZM 0.00%
EQ 0.32%
EQRX -2.09%
EQRXW 0.00%
ERAS -1.20%
ERNA 0.00%
ERYP 1.30%
ESLA 4.30%
ESLAW 87.05%
ETNB -0.51%
ETON 1.68%
ETTX 0.00%
EVAX -2.14%
EVGN 3.97%
EVLO 0.00%
EWTX -0.12%
EXAI -0.66%
EXEL -0.40%
EYEG -0.69%
EYEN 1.45%
EYPT 0.00%
FATE -7.80%
FBIO 0.59%
FBIOP 0.92%
FBLG -18.05%
FBRX -0.04%
FDMT -4.50%
FENC -1.29%
FGEN -5.93%
FHTX 1.91%
FIXX 0.77%
FMTX 0.00%
FNCH 8.87%
FOLD -2.68%
FREQ 4.76%
FRLN 0.15%
FRTX 0.00%
FSTX 0.00%
FTRE -0.04%
FULC -4.01%
FUSN 0.00%
FWBI 4.59%
FWP 0.00%
GALT -6.73%
GANX -1.54%
GBIO -2.12%
GBT 0.01%
GDTC 0.50%
GERN -4.32%
GHRS -2.16%
GLMD -2.33%
GLPG -2.27%
GLSI 2.76%
GLTO -0.57%
GLUE -2.37%
GLYC -9.86%
GMAB -0.50%
GMDA -18.25%
GMTX 0.00%
GNCA -85.71%
GNFT 0.00%
GNLX 0.88%
GNPX 0.98%
GNTA 3.94%
GOSS -9.79%
GOVX 5.00%
GOVXW -49.04%
GPCR -6.86%
GRAY -10.80%
GRCL 0.05%
GRNA -0.03%
GRNAW 8.91%
GRPH -2.75%
GRTS -1.02%
GRTX 2.57%
GTHX 0.45%
GUTS -5.54%
GXGXW 41.67%
GYRE -7.16%
HALO -1.49%
HARP 0.09%
HCWB -3.75%
HEPA 2.80%
HGEN -84.62%
HILS 5.66%
HLVX -0.31%
HOOK -0.02%
HOTH -2.70%
HOWL -2.14%
HRMY 0.66%
HRTX 3.61%
HSTO 0.00%
HUMA 0.30%
HUMAW -0.01%
IBRX -4.47%
ICCC 0.22%
ICPT 0.21%
ICU 15.23%
ICUCW 20.20%
ICVX -0.91%
IDRA -23.04%
IDYA -1.66%
IFRX -1.85%
IGMS -0.44%
IKNA 1.19%
IKT 1.42%
IMAB -0.29%
IMCR -3.22%
IMGN 0.02%
IMGO 0.00%
IMMP 5.70%
IMMX -7.33%
IMNM -1.56%
IMNN 0.88%
IMPL -27.27%
IMRA 15.96%
IMRN -1.18%
IMRX -0.35%
IMTX -1.67%
IMTXW 6.00%
IMUX 1.56%
IMV 0.00%
IMVT -3.99%
INAB 0.00%
INBX 0.53%
INCY -0.90%
INDP 11.07%
INFI -52.38%
INKT -0.01%
INM 1.49%
INMB 2.60%
INO -2.34%
INSM -1.11%
INTS -2.75%
INVA 0.22%
INZY 0.69%
IOBT -11.42%
IONS 0.13%
IOVA -2.43%
IPA 2.50%
IPHA 5.58%
IPSC -2.15%
IRON -2.94%
ISEE 0.38%
ITOS -1.90%
ITRM 1.67%
IVA 6.96%
IVVD -2.48%
JAGX 1.04%
JANX -4.24%
JAZZ -0.77%
JNCE 0.00%
JSPR -6.20%
JSPRW 20.88%
JUNS 0.00%
JUNSW 0.00%
KA -3.54%
KALV -1.99%
KDNY 0.22%
KMPH -0.34%
KNSA -2.89%
KNTE -0.38%
KOD -7.91%
KPRX 0.96%
KPTI -1.38%
KRBP -10.00%
KRON 1.05%
KROS -1.38%
KRRO -8.23%
KRTX 0.03%
KRYS -0.95%
KTRA 15.52%
KTTA 8.16%
KTTAW 0.92%
KURA -1.46%
KYMR -2.41%
KYTX -4.26%
KZIA 2.65%
KZR -0.93%
LABP 0.57%
LBPH -2.79%
LBPS 0.00%
LBPSW 14.81%
LEGN 1.82%
LENZ -3.71%
LEXX 1.16%
LEXXW -14.63%
LGND -1.30%
LGNDV 0.00%
LGVN -9.98%
LIAN -8.28%
LIFE 2.70%
LIPO -11.13%
LIXT -5.24%
LIXTW 63.57%
LJPC -0.32%
LMNL 0.12%
LOGC 1.09%
LPCN -3.93%
LPTX -1.65%
LQDA -1.06%
LRMR -2.20%
LSTA -4.06%
LTRN 1.37%
LUMO -1.32%
LVTX 0.00%
LXEO -4.21%
LXRX -2.06%
LYEL -33.33%
LYRA 1.17%
MACK 0.10%
MBIO -11.03%
MBRX -2.57%
MCRB 3.02%
MDGL -3.53%
MDNA -13.16%
MDWD -0.27%
MDXG -2.72%
MEIP -0.13%
MESO -1.93%
MGNX -3.03%
MGTA -7.74%
MGTX -3.33%
MGX 0.54%
MIRM -1.73%
MIRO 0.59%
MIST 0.76%
MITO 0.00%
MLEC -7.69%
MLECW 2.31%
MLND -5.36%
MLTX -0.83%
MLYS -6.90%
MNKD -1.15%
MNMD 0.42%
MNOV 2.11%
MNPR -5.01%
MOLN 0.28%
MOR 1.29%
MORF -3.34%
MREO -4.14%
MRKR 2.68%
MRNA -5.27%
MRNS -4.04%
MRSN -2.14%
MRTX -0.17%
MRUS 0.28%
MRVI -1.82%
MTCR -1.29%
MTEM 4.95%
MTP -18.50%
MURA -1.24%
MYMD 5.41%
NAMS 2.04%
NAMSW 0.43%
NAUT 1.56%
NBRV 0.71%
NBSE -1.56%
NBTX 8.61%
NCNA 1.82%
NERV -0.63%
NEXI 2.60%
NGM -1.28%
NGNE -1.93%
NKGN 10.62%
NKGNW 8.00%
NKTR -4.21%
NKTX -5.06%
NLSP 7.14%
NLSPW 26.67%
NMRA -2.96%
NMTR -42.97%
NOVN -24.84%
NRBO 9.15%
NRIX -0.39%
NRSN -6.31%
NRSNW 0.00%
NRXP -4.09%
NRXPW 18.33%
NRXS 4.82%
NTBL 5.06%
NTEC -12.45%
NTHI 0.00%
NTLA -5.58%
NTRBW -31.07%
NUVL -1.82%
NVAX -2.39%
NVCT 2.89%
NVIV -34.28%
NXTC -2.94%
NYMX -0.05%
OABI 0.40%
OABIW -10.06%
OBIO -3.35%
OBSV 0.00%
OCEA 0.00%
OCGN 3.81%
OCS -1.00%
OCUL -1.83%
OCUP 1.30%
ODT -4.27%
OKYO 1.51%
OLMA -6.05%
OMER -0.51%
OMGA 4.15%
ONCO 4.96%
ONCR -3.08%
ONCS 31.87%
ONCT -3.05%
ONCY -0.99%
ONTX -0.47%
ONVO 0.99%
OPNT 0.00%
OPT 2.06%
ORGS 0.67%
ORIC -3.56%
ORMP 21.77%
ORPH 0.00%
ORTX 0.30%
OSMT -1.77%
OTIC -92.64%
OTLK -2.36%
OVID -1.44%
OYST 0.00%
PALI 2.58%
PASG -1.30%
PBLA -7.50%
PBM -4.89%
PBYI 1.35%
PCSA 0.00%
PCVX -0.58%
PDSB -2.53%
PEPG 2.62%
PGEN -2.99%
PHAR 1.51%
PHAS 0.00%
PHAT -1.55%
PHIO -3.57%
PHIOW 36.47%
PHVS -7.37%
PHXM -5.20%
PIRS 0.58%
PKBO 0.00%
PKBOW 999 900.00%
PLRX -1.37%
PLUR 6.01%
PMN 0.72%
PMVP -0.30%
PNT 0.16%
PPBT -10.93%
PRAX 0.37%
PRDS 0.93%
PRLD -3.17%
PROG -3.47%
PROK -0.45%
PRQR -0.01%
PRTA -2.77%
PRTC 0.49%
PRTG -0.54%
PRTK 1.83%
PRVB 0.00%
PSTI -2.91%
PSTV -7.32%
PSTX -0.78%
PTCT -0.71%
PTE -0.82%
PTGX -1.89%
PTIXW -49.04%
PULM 2.60%
PXMD 0.00%
PYPD 0.07%
PYXS 1.96%
QLGN -4.39%
QNCX 5.70%
QNRX 0.37%
QSI -11.97%
QSIAW -3.13%
QTTB -1.83%
QURE -0.67%
RAIN -1.63%
RANI 6.42%
RAPT -3.57%
RARE 1.15%
RCKT -8.42%
REGN -0.38%
RENB -2.80%
REPL -2.83%
RETA 0.02%
REUN -0.89%
REVB -1.40%
REVBU 3.46%
REVBW 4.38%
RGLS -5.37%
RGNX -5.97%
RIGL -3.28%
RLAY -4.60%
RLMD 0.33%
RLYB -0.34%
RNA -0.08%
RNAC -5.94%
RNAZ -0.96%
RNXT 1.88%
ROIV -2.12%
ROIVW 4.56%
RPHM -0.31%
RPRX 0.13%
RPTX -2.64%
RUBY 2.70%
RVLP -32.05%
RVMD -1.25%
RVMDW -30.00%
RVNC 1.92%
RVPH -1.60%
RVPHW 1.62%
RXDX 0.09%
RXRX -3.57%
RYTM -6.74%
RYZB 0.02%
RZLT 1.16%
SABS -1.37%
SABSW -11.81%
SAGE 1.47%
SANA -4.05%
SAVA -0.73%
SAVAW 0.00%
SBBP 1.52%
SBTX 1.03%
SCNI 5.50%
SCPH 2.40%
SCPS 0.00%
SEEL -5.26%
SEER 0.59%
SELB -8.00%
SESN 7.29%
SGEN -0.07%
SGMO 0.22%
SGMT -1.93%
SGTX -2.56%
SIOX 22.63%
SLDB -5.69%
SLGL 2.97%
SLN -4.76%
SLNO -4.08%
SLRX 6.07%
SLS -2.14%
SMMT -2.62%
SNDX 1.20%
SNGX -3.42%
SNPX -0.79%
SONN -1.08%
SPPI -0.49%
SPRB 1.52%
SPRC -2.75%
SPRO 0.05%
SRNE -34.00%
SRPT -1.30%
SRRA 0.00%
SRRK -2.60%
SRZN -2.45%
STAB 0.00%
STOK -5.27%
STRO -3.01%
STSA 0.00%
STTK -2.68%
SURF -0.93%
SVRA -4.74%
SWTX -0.03%
SYBX -1.94%
SYRS -1.03%
TALS -0.73%
TARA -6.68%
TARS -0.41%
TBPH 0.30%
TCBP 2.47%
TCDA 0.00%
TCON 0.00%
TCRR 0.00%
TCRT 1.59%
TCRX 1.45%
TECH -0.16%
TENX -1.27%
TERN -7.83%
TFFP -5.21%
TGTX -3.23%
THRX 0.12%
TIL -1.09%
TLC 0.00%
TLSA -2.11%
TNGX -2.92%
TNXP -4.81%
TNYA -6.83%
TPST 3.40%
TRDA -3.93%
TRVI 1.92%
TRVN 2.97%
TSHA -24.95%
TSVT -3.19%
TTNP -9.27%
TVTX 0.76%
TYRA -6.83%
UBX -2.12%
UNCY -3.90%
URGN -1.17%
UTHR -0.55%
VACC 11.36%
VALN -2.89%
VAXX 68.75%
VBIV 0.78%
VBLT -8.77%
VCEL -0.42%
VCNX 10.35%
VCYT -1.03%
VERA -3.85%
VERU -0.57%
VERV -2.87%
VIGL 7.53%
VINC 3.00%
VIR 0.65%
VIRI -1.61%
VIRX 2.40%
VKTX -1.46%
VLON -13.04%
VNDA -2.69%
VOR -1.61%
VRCA 0.14%
VRDN -4.47%
VRNA -1.66%
VRPX 0.38%
VRTX 0.28%
VSTM -2.55%
VTGN -1.05%
VTVT -2.97%
VTYX -1.26%
VXRT -4.05%
VYGR -1.53%
VYNE -4.62%
VYNT 7.78%
WINT -3.24%
WVE -4.40%
XBIO 0.93%
XBIT -1.46%
XCUR 3.58%
XENE -3.14%
XERS 1.67%
XFOR 2.80%
XLO 4.54%
XLRN 0.00%
XNCR 0.21%
XOMA -2.94%
XOMAO 0.36%
XOMAP -0.82%
XRTX -8.00%
YMAB -1.96%
ZGNX 0.00%
ZIOP -0.88%
ZLAB -2.87%
ZNTL -0.95%
ZSAN 0.00%
Insider Trading
Date Person Action Amount type
2024-06-05 Patou Gary Buy 15 542 Stock Option (Right to Buy)
2024-06-05 Machado Patrick Buy 15 542 Stock Option (Right to Buy)
2024-06-05 Gover Justin D. Buy 15 542 Stock Option (Right to Buy)
2024-06-05 Garofalo Elizabeth A. Buy 15 542 Stock Option (Right to Buy)
2024-06-05 Gannon Steven Buy 15 542 Stock Option (Right to Buy)
INSIDER POWER
65.51
Last 100 transactions
Buy: 2 285 491 | Sell: 531 159
Correlation (AI algo v.1.1b): Undervalued: 0.27% $36.05 paired level. (The Algo Track The Changes Of The Most Correlated Stocks In Realtime And Give An Instant Update)

Volume Correlation

Long: 0.46 (neutral)
Short: -0.76 (moderate negative)
Signal:(51.525) Neutral

Xenon Pharmaceuticals Inc Correlation

10 Most Positive Correlations
ZS0.893
IRWD0.887
DMRC0.873
TNGX0.872
WRAP0.868
TACT0.862
TBBK0.862
MDB0.861
ASUR0.86
NEPH0.858
10 Most Negative Correlations
TIGO-0.885
IGLD-0.877
GLDI-0.865
MRVI-0.845
BZFD-0.844
PPC-0.843
SLVO-0.843
KNTK-0.842
SANG-0.841
KALU-0.84

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Xenon Pharmaceuticals Inc Correlation - Currency/Commodity

The country flag -0.80
( moderate negative )
The country flag -0.30
( neutral )
The country flag 0.00
( neutral )
The country flag -0.57
( weak negative )
The country flag 0.19
( neutral )
The country flag -0.16
( neutral )

Xenon Pharmaceuticals Inc Financials

Annual 2023
Revenue: $0
Gross Profit: $-3.54M (0.00 %)
EPS: $-2.73
FY 2023
Revenue: $0
Gross Profit: $-3.54M (0.00 %)
EPS: $-2.73
FY 2022
Revenue: $9.43M
Gross Profit: $-96.33M (-1 021.13 %)
EPS: $-2.07
FY 2021
Revenue: $18.44M
Gross Profit: $0.00 (0.00 %)
EPS: $-1.770

Financial Reports:

No articles found.

Xenon Pharmaceuticals Inc Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Xenon Pharmaceuticals Inc

Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopathy; and XEN1101, A Kv7 potassium channel opener, which is in Phase II clinical trial for the treatment of epilepsy and other neurological disorders. The company's product candidates also comprise NBI-921352, a selective Nav1.6 sodium channel inhibitor that is in Phase II clinical trials for the treatment of SCN8A developmental and epileptic encephalopathy, and other potential indications, including adult focal epilepsy; and XEN007, A central nervous system-acting calcium channel modulator, which is in Phase II clinical trials. It has a license and collaboration agreement with the Neurocrine Biosciences, Inc. to develop treatments for epilepsy; and with Flexion Therapeutics, Inc. to develop PCRX301 (XEN402, a Nav1.7 inhibitor) for the treatment of post-operative pain. Xenon Pharmaceuticals Inc. was incorporated in 1996 and is headquartered in Burnaby, Canada.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators

Total Execution Time: 1.5324409008026 seconds
Number of API calls: 3
Number of DB calls: 9